NCT06302426 2026-01-16Trial of INI-4001 in Patients With Advanced Solid TumoursInimmune CorporationPhase 1 Recruiting50 enrolled
NCT03192345 2024-08-07A First-in-human Study of the Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of SAR439459 Monotherapy and Combination of SAR439459 and Cemiplimab in Patients With Advanced Solid TumorsSanofiPhase 1 Completed161 enrolled